← Back to directory
Howard Streicher
Researcher Next ID · RN-013738
Researcher · Medicine
, Ukraine
Not currently recruitingFunding unknown
- Works count
- 304
- Citation count
- 8,663
- H-index
- 45
- i10-index
- 90
Research interests
Medicine
Immunology and Microbiology
Cancer Immunotherapy and Biomarkers
Immunotherapy and Immune Responses
Bladder and Urothelial Cancer Treatments
CAR-T cell therapy research
Renal cell carcinoma treatment
Publications
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134
Journal of Clinical Oncology · 2022 · 10.1200/jco.22.01763
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
The Lancet Oncology · 2018 · 10.1016/s1470-2045(18)30006-8
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
New England Journal of Medicine · 2016 · 10.1056/nejmoa1601202
Current projects
No projects listed.